For example, GSK2606414, the first reported PERK inhibitor, inhibits the PERK-mediated UPR and increases the amount of misfolded proteins in the ER [227], resulting in cancer cell apoptosis (Table 1). This evidence concerns the gene EIF2AK3 and cancer.